Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction and Reduction of Central Line Associated Blood Stream Infections: A Machine Learning Improvement Study

NCT07108660 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT07108660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07108660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction and Reduction of Central Line Associated Blood Stream Infections: A Machine Learning Improvement Study
Lead sponsor
Swedish Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
December 31, 2027
Enrollment
17,800 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

central line associated blood stream infections (clabsi)